Essex Investment Management Co. LLC reduced its position in Integral Ad Science Holding Corp. (NASDAQ:IAS – Free Report) by 12.9% during the fourth quarter, HoldingsChannel.com reports. The firm owned 129,301 shares of the company’s stock after selling 19,155 shares during the period. Essex Investment Management Co. LLC’s holdings in Integral Ad Science were worth $1,350,000 at the end of the most recent quarter.
Other institutional investors have also added to or reduced their stakes in the company. US Bancorp DE lifted its position in shares of Integral Ad Science by 540.9% during the third quarter. US Bancorp DE now owns 35,776 shares of the company’s stock worth $387,000 after purchasing an additional 30,194 shares during the last quarter. TimesSquare Capital Management LLC increased its stake in Integral Ad Science by 0.6% in the 3rd quarter. TimesSquare Capital Management LLC now owns 2,772,440 shares of the company’s stock worth $29,970,000 after buying an additional 17,166 shares during the period. Oppenheimer & Co. Inc. bought a new stake in Integral Ad Science during the 3rd quarter valued at about $281,000. Quest Partners LLC boosted its position in Integral Ad Science by 101,255.9% in the 3rd quarter. Quest Partners LLC now owns 34,461 shares of the company’s stock valued at $373,000 after buying an additional 34,427 shares during the period. Finally, Jennison Associates LLC bought a new position in Integral Ad Science in the 3rd quarter worth about $665,000. Institutional investors own 95.78% of the company’s stock.
Wall Street Analysts Forecast Growth
IAS has been the subject of several research analyst reports. Scotiabank initiated coverage on shares of Integral Ad Science in a research note on Friday, February 28th. They set a “sector perform” rating and a $12.00 price target for the company. Morgan Stanley lifted their target price on Integral Ad Science from $13.00 to $13.50 and gave the company an “equal weight” rating in a research report on Monday, March 3rd. Benchmark reissued a “hold” rating on shares of Integral Ad Science in a research report on Friday, February 28th. Truist Financial lifted their price objective on Integral Ad Science from $16.00 to $17.00 and gave the company a “buy” rating in a report on Monday, March 3rd. Finally, Oppenheimer reiterated an “outperform” rating on shares of Integral Ad Science in a report on Friday, February 28th. Four analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $15.06.
Insider Transactions at Integral Ad Science
In related news, CEO Lisa Utzschneider sold 12,448 shares of Integral Ad Science stock in a transaction that occurred on Tuesday, February 4th. The shares were sold at an average price of $10.61, for a total value of $132,073.28. Following the completion of the sale, the chief executive officer now directly owns 278,650 shares in the company, valued at $2,956,476.50. This trade represents a 4.28 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders sold 19,109 shares of company stock valued at $197,696 in the last quarter. 2.00% of the stock is currently owned by corporate insiders.
Integral Ad Science Stock Performance
Shares of Integral Ad Science stock opened at $10.26 on Monday. Integral Ad Science Holding Corp. has a one year low of $7.98 and a one year high of $13.62. The company has a market capitalization of $1.68 billion, a PE ratio of 51.30, a P/E/G ratio of 1.06 and a beta of 1.45. The company has a debt-to-equity ratio of 0.07, a quick ratio of 3.71 and a current ratio of 3.71. The company has a 50-day simple moving average of $10.33 and a two-hundred day simple moving average of $10.79.
Integral Ad Science (NASDAQ:IAS – Get Free Report) last posted its earnings results on Friday, February 28th. The company reported $0.09 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.03). Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The firm had revenue of $153.00 million for the quarter, compared to analysts’ expectations of $148.83 million. During the same period in the previous year, the company earned $0.06 EPS. The company’s revenue was up 13.9% on a year-over-year basis. Research analysts expect that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.
Integral Ad Science Profile
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Further Reading
- Five stocks we like better than Integral Ad Science
- Consumer Staples Stocks, Explained
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- The Significance of Brokerage Rankings in Stock Selection
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Want to see what other hedge funds are holding IAS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integral Ad Science Holding Corp. (NASDAQ:IAS – Free Report).
Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.